In addition, studies in ovarian cancer models have implicated auranofin as a potent activator of the FOXO3 tumor suppressor [34], as well as a selective inhibitor of oncogenic protein kinase C iota (PKCι) signaling [35]. The gene discussed is PRKCI; the disease is ovarian cancer.